Kazia Therapeutics Limited – Filings and Transcripts

NASDAQ: KZIA
Share price (6/2/26): $11.79
Market cap (6/2/26): $135 million

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Financials Filter

ended 06/30/25 FY 2025

Late filing notification for annual report of foreign issuer

ended 06/30/24 FY 2024

Late filing notification for annual report of foreign issuer

ended 06/30/23 FY 2023

Prospectuses and Registrations Filter

Prospectus supplement

Prospectus supplement

Prospectus supplement

Prospectus supplement

Prospectus supplement

Ownership Filter

Friend John E. II

News Filter

Appoints James Levine as Chief Financial Officer

Expands Ongoing Phase 1b Trial of Paxalisib in Advanced Breast Cancer

Investor Presentation

Strengthens Scientific Leadership With Appointment of Dr. Sudha Rao as Chief Scientific Officer to Lead Next-Generation Oncology Platform

Expands Oncology Platform With First-In-Class SETDB1 Inhibitor Drug Development Platform

Proxies

No filings in this category.

Other Filter

Notice of effectiveness

Correspondence with the SEC

Letter from the SEC

Notice of effectiveness

Notice of effectiveness